-
公开(公告)号:EP2773365A4
公开(公告)日:2015-05-20
申请号:EP12846423
申请日:2012-11-02
申请人: KEYBIOSCIENCE AG
CPC分类号: C07K14/585 , A61K38/23
摘要: Use of a peptide having SEQ ID NO: 18 for the treatment of type I diabetes, Type II diabetes, metabolic syndrome, or obesity, or of apetite suppression, or for mitigating insulin resistance, or for reducing an undesirably high fasting serum glucose level, or for reducing an undesirably high peak serum glucose level, or for reducing an undesirably high peak serum insulin level, or for reducing an undesirably large response to a glucose tolerance test.